<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Available immune globulin (immunoglobulin) products and their properties</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Available immune globulin (immunoglobulin) products and their properties</h1>
<div class="graphic"><div class="figure"><div class="ttl">Available immune globulin (immunoglobulin) products and their properties</div><div class="cntnt"><table cellspacing="0"><colgroup span="12" width="8%"></colgroup> <tbody> <tr> <td class="subtitle1">Route</td> <td class="subtitle1">Product</td> <td class="subtitle1">Dosage form</td> <td class="subtitle1">Diluent</td> <td class="subtitle1">Refrigeration required?</td> <td class="subtitle1">Filtration required?</td> <td class="subtitle1">Osmolality<br/> (mOsm/kg)</td> <td class="subtitle1">Sodium</td> <td class="subtitle1">pH</td> <td class="subtitle1">IgA<br/> (mcg/mL)</td> <td class="subtitle1">Stabilizer or regulator<sup>*</sup></td> <td class="subtitle1">Pathogen inactivation/<br/> removal<sup>¶</sup></td> </tr> <tr> <td rowspan="11"><strong>IV</strong></td> <td>Asceniv</td> <td>10% liquid</td> <td>NA</td> <td>Yes</td> <td>No</td> <td>Not available</td> <td>0.100 to 0.140 mol/L</td> <td>4.0 to 4.6</td> <td>&lt;200</td> <td>Glycine and polysorbate 80</td> <td>FP, S/D, VF</td> </tr> <tr> <td>Bivigam</td> <td>10% liquid</td> <td>NA</td> <td>Yes</td> <td>No</td> <td>&lt;510</td> <td>100 to 140 mM</td> <td>4.0 to 4.6</td> <td>≤200</td> <td>Glycine</td> <td>FP, S/D, NF</td> </tr> <tr> <td>Flebogamma DIF 5%</td> <td>5% liquid</td> <td>NA</td> <td>No<sup>Δ</sup></td> <td>Optional</td> <td>240 to 370</td> <td>Trace</td> <td>5.0 to 6.0</td> <td>&lt;50</td> <td>D-sorbitol</td> <td>Past, S/D, dsNF, FP, PEG, pH4</td> </tr> <tr> <td>Flebogamma DIF 10%</td> <td>10% liquid</td> <td>NA</td> <td>No<sup>Δ</sup></td> <td>No</td> <td>240 to 370</td> <td>Trace</td> <td> </td> <td>&lt;100</td> <td>D-sorbitol</td> <td>Past, S/D, dsNF, FP, PEG, pH4</td> </tr> <tr> <td>Gammagard 5% S/D</td> <td>Lyophilized</td> <td>Sterile water</td> <td>No</td> <td>Yes</td> <td>636</td> <td>8.5 mg/mL</td> <td>6.8</td> <td>&lt;1</td> <td>2% glucose and glycine</td> <td>CEF, CHROM, S/D</td> </tr> <tr> <td>Gammaplex</td> <td>5% liquid</td> <td>NA</td> <td>No<sup>Δ</sup></td> <td>15 to 20 micron filter preferred</td> <td>420 to 500</td> <td>30 to 50 mmol/L</td> <td>4.8 to 5.0</td> <td>&lt;4</td> <td>Sorbitol and glycine and polysorbate 80</td> <td>S/D, VF, low pH</td> </tr> <tr> <td>Gammaplex</td> <td>10% liquid</td> <td>NA</td> <td>No<sup>Δ</sup></td> <td>No</td> <td>≥280</td> <td>&lt;30 mM/L</td> <td>4.9 to 5.2</td> <td>&lt;20</td> <td>Glycine and polysorbate 80</td> <td>S/D, VF, low pH</td> </tr> <tr> <td>Octagam</td> <td>5% liquid</td> <td>NA</td> <td>No<sup>Δ</sup></td> <td>Optional</td> <td>310 to 380</td> <td>0.03 mEq/mL</td> <td>5.1 to 6.0</td> <td>&lt;200</td> <td>Maltose</td> <td>CEF, UF, CHROM, S/D, pH4</td> </tr> <tr> <td>Octagam</td> <td>10% liquid</td> <td>NA</td> <td>No<sup>Δ</sup></td> <td>Optional</td> <td>310 to 380</td> <td>&lt;30 mmol/L</td> <td>4.5 to 5.0</td> <td>106</td> <td>Maltose</td> <td>CEF, S/D, pH 4, UF, CHROM</td> </tr> <tr> <td>Panzyga</td> <td>10% liquid</td> <td>NA</td> <td>No<sup>◊</sup></td> <td>Optional</td> <td>240 to 310</td> <td>Trace</td> <td>4.5 to 5.0</td> <td>100</td> <td>Glycine</td> <td>S/D, CEF, NF, CHROM</td> </tr> <tr> <td>Privigen</td> <td>10% liquid</td> <td>NA</td> <td>No</td> <td>No</td> <td>240 to 440</td> <td>Trace</td> <td>4.6 to 5.0</td> <td>&lt;25</td> <td>L-proline</td> <td>CEF, CHROM, pH 4, DF, NF, OAF</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="3"><strong>IV or SC</strong></td> <td>Gammagard liquid</td> <td>10% liquid</td> <td>NA</td> <td>No<sup>Δ</sup></td> <td>Optional</td> <td>240 to 300</td> <td>None added</td> <td>4.6 to 5.1</td> <td>37</td> <td>Glycine</td> <td>CEF, CHROM, S/D, pH 4, NF</td> </tr> <tr class="highlight_lght_gray_text"> <td>Gammaked</td> <td>10% liquid</td> <td>NA, incompatible with saline</td> <td>No<sup>§</sup></td> <td>No</td> <td>258</td> <td>None added</td> <td>4.0 to 4.5</td> <td>46</td> <td>Glycine</td> <td>CEF, pH 4.2, DF, CAP, CHROM, NF</td> </tr> <tr class="highlight_lght_gray_text"> <td>Gamunex-C</td> <td>10% liquid</td> <td>NA, incompatible with saline</td> <td>No<sup>§</sup></td> <td>No</td> <td>258</td> <td>None added</td> <td>4.0 to 4.5</td> <td>46</td> <td>Glycine</td> <td>CEF, pH 4.2, DF, CAP, CHROM</td> </tr> <tr> <td rowspan="5"><strong>SC</strong></td> <td>Cutaquig</td> <td>16.5%</td> <td>NA</td> <td>Yes<sup>¥</sup></td> <td>No</td> <td>310 to 380</td> <td>&lt;30 mmol/L</td> <td>5.0 to 5.5</td> <td>≤600</td> <td>Maltose</td> <td>CEF, UF, CHROM, S/D, pH 4</td> </tr> <tr> <td>Cuvitru</td> <td>20% solution</td> <td>NA</td> <td>No<sup>‡</sup></td> <td>No</td> <td>208 to 290</td> <td>None</td> <td>4.6 to 5.1</td> <td>80</td> <td>Glycine</td> <td>CEF, CHROM, NF, S/D</td> </tr> <tr> <td>Hizentra</td> <td>20% liquid</td> <td>NA</td> <td>No</td> <td>No</td> <td>380</td> <td>Trace, &lt;10 mmol/L</td> <td>4.6 to 5.2</td> <td>≤50</td> <td>Proline</td> <td>CEF, CHROM, pH 4.2, DF, NF, VF, OAF</td> </tr> <tr> <td>Hyqvia</td> <td>10% liquid + hyaluronidase, human recombinant</td> <td>NA</td> <td>No</td> <td>No<sup>†</sup></td> <td>240 to 300</td> <td>None added</td> <td>4.6 to 5.1</td> <td>37</td> <td>Glycine</td> <td>CEF, CHROM, S/D, pH 4, NF</td> </tr> <tr> <td>Xembify</td> <td>20%</td> <td>NA</td> <td>2 to 8°C</td> <td>No</td> <td>280 to 404</td> <td>None</td> <td>4.1 to 4.8</td> <td>Not defined</td> <td>Glycine</td> <td>CEF, CHROM, CAP, NF, DF, low pH</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="2"><strong>Intramuscular</strong></td> <td>GamaSTAN</td> <td>16.5% solution</td> <td>NA</td> <td>2 to 8°C</td> <td>No</td> <td>Not available</td> <td>Not measured</td> <td>4.1 to 4.8</td> <td>Not measured</td> <td>Glycine</td> <td>CEF, CAP, CHROM, NF, low pH, DF</td> </tr> <tr class="highlight_lght_gray_text"> <td>GamaSTAN S/D<sup>**</sup></td> <td>15 to 18% liquid</td> <td>NA</td> <td>2 to 8°C</td> <td>No</td> <td>Not available</td> <td>0.4 to 0.5%</td> <td>6.4 to 7.2</td> <td>Not measured</td> <td>Glycine</td> <td>CEF, S/D, UF</td> </tr> </tbody></table></div><div class="graphic_lgnd">Brand names and descriptions refer to products available in the United States and some other countries; product availability, specific composition, and other details regarding individual products vary in other countries. Refer to additional UpToDate topics on immune globulin therapy and product inserts for the indications and use of these products.</div><div class="graphic_footnotes"><p>CAP: caprylate; CEF: cold ethanol fractionation; CHROM: chromatography; DF: depth filtration; DIF: dual inactivation and filtration; dsNF: double sequential nanofiltration; FP: fraction precipitation; IgA: immunoglobulin A; IV: intravenous; NA: not applicable; Nano, NF: nanofiltration; OAF: octanoic acid fractionation; Past: pasteurization; PEG: polyethylene glycol precipitation; S/D: solvent detergent; SC: subcutaneous; UF: ultrafiltration; VF: virus filtration.</p>
* Precautions and laboratory abnormalities associated with specific stabilizers include the following. For additional information, refer to UpToDate clinical topics, immune globulin drug monograph, and labeling for specific products.
<ul>
<li>Glucose: May alter glycemic control in patients with diabetes mellitus</li>
<li>L-proline: Cannot be used in patients with hyperprolinemia</li>
<li>Maltose: Falsely elevates glucose readings in certain blood glucose monitoring systems; may contain trace corn protein (potential allergen); may increase plasma osmolality (usually not clinically important)</li>
<li>Polysorbate 80: Some patients may be hypersensitive (also known as Tween 80); reactions can be delayed type</li>
<li>Sorbitol, D-sorbitol: Cannot be used in patients with hereditary fructose intolerance</li>
<li>Sucrose: Avoid in patients with renal impairment or increased risk of acute kidney injury</li>
</ul>
<p class="extra_spacing">¶ Pathogen inactivation/removal using CEF, DF, UF, CAP, CHROM, Nano, double sequential nanofiltration, VF, S/D, Past, FP, or OAF.</p>
<p>Δ Not required (+2 to 25°C).</p>
<p>◊ Storage is 2 to 8°C for 24 months or 25°C for 9 months.</p>
<p>§ Storage is 2 to 8°C for 36 months or 25°C for 6 months.</p>
<p>¥ Storage is 2 to 8°C for 24 months or 25°C for 6 months.</p>
<p>‡ Storage is 2 to 8°C for 36 months or 25°C for 12 months.</p>
<p>† Storage is 2 to 8°C for 36 months or 25°C for 3 months.</p>
** GamaStan S/D has been discontinued in the United States.</div><div class="graphic_reference"><p>Original table modified for this publication. From: Perez EE, Orange JS, Bonilla F, et al. Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol 2017; 139:S1. Table used with the permission of Elsevier Inc. All rights reserved.</p>
Additional data from:
<ol>
<li>US Food &amp; Drug Administration. Licensed biological products with supporting documents. Available at: <a href="https://www.fda.gov/vaccines-blood-biologics/licensed-biological-products-supporting-documents" target="_blank">https://www.fda.gov/vaccines-blood-biologics/licensed-biological-products-supporting-documents</a> (Accessed on February 20, 2020).</li>
<li>Characteristics of Immunoglobulin Products Used to Treat Primary Immunodeficiencies, Immune Deficiency Foundation. Available at: <a href="https://primaryimmune.org/publication/characteristics-ig-products-used-treat-pi-licensed-use-us" target="_blank">https://primaryimmune.org/publication/characteristics-ig-products-used-treat-pi-licensed-use-us</a> (Accessed on January 23, 2023).</li>
</ol></div><div id="graphicVersion">Graphic 116460 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
